Search

Morning-After Pill

Under the Table: Why the U.S. Food and Drug Administration Should Not Approve the Over-the Counter Distribution of Morning After Pills

May 2, 2004 No Comments

Published by Population Research Institute Research by Julie Wheeland Executive Summary In May 2004, The U.S. Food and Drug Administraion (FDA) will act on Women’s Capital Corporation/Barr Laboratories application for over-the-counter (OTC) status for so-called “emergency contraception” (EC), the morning-after pill (MAP). Opposition to OTC/MAP

Read More »

OTC/MAP Means Danger for American Girls

April 16, 2004 No Comments

April 16, 2004 Volume 6 / Number 15 Dear Colleague: Over-the-counter (OTC) availability of the morning-after pill (MAP)-so called “emergency contraception” or EC- would increase rates of abortion, disease, sexual promiscuity, and sexual violence committed against American teens. OTC/MAP means danger for American girls. Steven

Read More »

Morning-After Pills: Domestic and International Links

April 2, 2004 No Comments

April 2, 2004 Volume 6 / Number 13 Dear Colleague: The efforts to pressure the U.S. Food and Drug Administration (FDA) into approving the morning-after pill (MAP) for over-the-counter (OTC) distribution are inextricably linked to the international abortion industry. The founder of Women’s Capital Corporation,

Read More »

New Report on FDA Approval of ‘Emergency Contraception’

March 31, 2004 No Comments

Press Release Source: Population Reseach New Report on FDA Approval of ‘Emergency Contraception’ WASHINGTON, DC, 31 March 2004 — Population Research Institute has released an in-depth report on so-called “emergency contraception.” The U.S. Food and Drug Administration (FDA) has delayed its decision to act on

Read More »

Dangerous MAP Ads Threaten Public Health

March 26, 2004 No Comments

March 26, 2004 Volume 6 / Number 12 Dear Colleague: On February 20, 2004, the Food and Drug Administration (FDA) announced it would delay for 90 days its decision to approve over-the-counter (OTC) status of the morning-after pill (MAP). The FDA said it needed more

Read More »

The Morning-After Pill and Abortion

March 19, 2004 No Comments

March 19, 2004 Volume 6 / Number 11 Dear Colleague: In rejecting Plan B’s application to approve the morning-after abortion pill (MAP) for over-the-counter (OTC) distribution, the FDA should also designate this chemical as an abortion drug.  The medical establishment, which has abandoned the science

Read More »

The Morning-After Pill and the Dangers to Adolescents

March 1, 2004 No Comments

Updated February 14, 2020 The makers and promoters of “emergency contraception” (EC), the morning-after pill (MAP), see vast profits from teen consumers if over-the-counter (OTC) approval is given by the FDA. The promotion of MAP to adolescents has involved dangerous trials, which have exposed the

Read More »

The Dangers of the Morning-After Pill | Taking Plan B Too Much

March 1, 2004 No Comments

Updated January 3, 2020 In the mid-nineties, the World Health Organization (WHO) began to realize that increased access to routine methods of contraception led to increased rates of abortion. So a new method of post-coital “contraception” was zealously sought and promoted: the morning-after pill.1 WHO

Read More »
Publications
Search